Cardiometabolic Health Congress (CMHC) | VuMedi

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress (CMHC)

The global epidemic of metabolic syndrome, a constellation of cardiometabolic risk factors, and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH, have become the modern-day health hazard across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as ...
read more ↘ smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. Overall, the numbers are particularly striking. There are more than 463 million adults living with diabetes worldwide, and the number is expected to rise to more than 700 million by 2045.1 Furthermore, 232 million have undiagnosed diabetes with an additional 374 million having prediabetes.1 The increasing prevalence of overweight and obesity (now estimated to affect 2 billion adults, or nearly 30% of the world population), high cholesterol (>40% of the world’s population), and hypertension (>1 billion), together with type 2 diabetes (T2D), are some of the major drivers of morbidity and mortality worldwide.2-4 They affect multiple organ systems, including the heart, liver, and kidneys, spanning several disease domains and outcomes.

Although clinicians are learning more about the interconnections between these conditions and risk factors, the application of these principles to patient care remains in its infancy. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is unfortunately what tends to happen in clinical practice. The Cardiometabolic Health Congress (CMHC) has been at the forefront of looking at the whole spectrum of cardiometabolic disease, including obesity, diabetes, lipids, hypertension, cardio-renal disease, and practical ways to address them. Through our live conferences and extensive online education platforms, we strive to synthesize and translate the latest cutting-edge medical research into practical clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
↖ read less

CMHC Tsunami

Cardiometabolic Health Congress (CMHC)

CMHC Tsunami Expert Discussion on Obesity, Nutrition/Physical Activity Tips, Out-Of-Clinic BP Monitoring

FEATURING Harold Bays, Keith Ferdinand, Donna Ryan, Karol Harshaw-Ellis, Ileana Pina, Erin Michos, Anne Peters, Daichi Shimbo, Ahmed Soliman

466 views
January 21, 2021

Cardiometabolic Health Congress (CMHC)

Telemedicine for Lipid Management: How Can Telehealth Platforms Help Us to Improve Patient Care? How to Do a Physical Exam, and What Are the CV Prevention Strategies?

FEATURING Erin Michos

12 views
January 21, 2021

Cardiometabolic Health Congress (CMHC)

Telemedicine for Glucose Monitoring: What Types Are There? How to Set Up a Virtual Clinic?

FEATURING Anne Peters

247 views
January 21, 2021
1

Cardiometabolic Health Congress (CMHC)

What Are the Current Blood Pressure Monitoring Trends?

FEATURING Daichi Shimbo

102 views
January 21, 2021

Cardiometabolic Health Congress (CMHC)

Telemedicine for BP Monitoring: Are Telehealth Strategies Efficient for Hypertension Diagnosis/Management? What Are the Types of Out-Of-Clinic BP Monitoring?

FEATURING Daichi Shimbo

48 views
January 21, 2021

Cardiometabolic Health Congress (CMHC)

Reimbursement for Telemedicine: How to Establish Remote Monitoring?

FEATURING Ahmed Soliman

391 views
January 19, 2021

Cardiometabolic Health Congress (CMHC)

Chronic Pain Management With Telemedicine: How to Build/Rearrange Your Tele-Practice?

FEATURING Ahmed Soliman

10 views
January 19, 2021

Cardiometabolic Health Congress (CMHC)

Acute/Chronic HF Management: What Is the Effectiveness of Traditional vs. Post-Discharge vs. Transitional Care?

FEATURING Karol Harshaw-Ellis

5 views
January 19, 2021

Cardiometabolic Health Congress (CMHC)

Communication in HF: What Are the Components of High-Quality Disease Management, and the Tools for Effective Communication?

FEATURING Karol Harshaw-Ellis

3 views
January 19, 2021

Cardiometabolic Health Congress (CMHC)

Multimorbidity Management in HF: How to Optimize Health Outcomes With ARISE-HF Framework? What Are the Available Tools for Medication Management?

FEATURING Karol Harshaw-Ellis

23 views
January 19, 2021

Cardiometabolic Health Congress (CMHC)

Epidemiology of Heart Failure: Why Is HF Increasing? What Are the Outcomes in Hospitalized Patients?

FEATURING Ileana Pina

787 views
January 18, 2021
2

Cardiometabolic Health Congress (CMHC)

Management of Comorbidities in HF: What Are the Recommendations for Anemia, Sleep Disorders, and Hypertension?

FEATURING Ileana Pina

422 views
January 18, 2021
2

Cardiometabolic Health Congress (CMHC)

HF Management Goals: What Is Precision Medicine, and When to Use It? What Are the ACC/AHA/HFSA Therapy Recomendations?

FEATURING Ileana Pina

295 views
January 18, 2021
2

Cardiometabolic Health Congress (CMHC)

Pearls and Tips on Obesity Management: How Do You Talk to a Patient Who Needs to Address Obesity? What Are the Long-Term Strategies?

FEATURING Donna Ryan

617 views
January 18, 2021
1

Cardiometabolic Health Congress (CMHC)

ASCVD Risk Reduction Recommendations: Who Benefits From High Intensity Statins? Which Non-Statin Therapies to Choose? What Is the Efficacy of Inclisiran in Patients With Elevated LDL Cholesterol?

FEATURING Margo Minissian

165 views
January 18, 2021
1

Cardiometabolic Health Congress (CMHC)

Trial Update on SGLT-2 Inhibitors in Heart Failure: What Is the Impact of SGLT2i on CV Outcomes, and How to Start Applying Them in Practice?

FEATURING Darren K. Mcguire

492 views
January 18, 2021
1

Cardiometabolic Health Congress (CMHC)

Obesity Novel Therapy Concepts: What Is the Role of Efficiency/Inefficiency in Energy Expenditure?

FEATURING Harold Bays

392 views
January 15, 2021
3

Cardiometabolic Health Congress (CMHC)

Obesity Pharmaceutical Management: What Are the Existing & Future Anti-Obesity Drug Treatments? Do They Have Contraindications for Hypersensitivity and Pregnancy?

FEATURING Harold Bays

508 views
January 15, 2021
2

Cardiometabolic Health Congress (CMHC)

Who Is an Obesity Medicine Specialist, and Why?

FEATURING Harold Bays

94 views
January 15, 2021
1

Cardiometabolic Health Congress (CMHC)

CMHC Tsunami Expert Discussion on Nutrition, Insulin Therapy, Practical Tips for Telemedicine, and the Link Between Hyperinsulinemia & Atherosclerosis

FEATURING Margo Minissian, Robert Eckel, Keith Ferdinand

60 views
January 15, 2021

Cardiometabolic Health Congress (CMHC)

Lipids/BP & ASCVD Risk Reduction Guidelines: What Are the Nutrition and Lifestyle Recommendations? How to Implement SGLT2i for CV Disease in T2DM?

FEATURING Margo Minissian

245 views
January 15, 2021

Cardiometabolic Health Congress (CMHC)

SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Have We Learned From CVOTs in T2DM? Is MACE Independent of Glucose Lowering?

FEATURING Robert Eckel

271 views
January 15, 2021
3

Cardiometabolic Health Congress (CMHC)

SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Are the Beneficial Effects on Reducing CVD Events?

FEATURING Robert Eckel

184 views
January 15, 2021

Cardiometabolic Health Congress (CMHC)

DKD & SGLT-2 Inhibitors: Can They Reduce Risks of Albuminuria, eGFR Decline, ESKD, HF, and CVD in Non-Diabetic/T2D Patients?

FEATURING Katherine R. Tuttle

766 views
January 15, 2021
4

Cardiometabolic Health Congress (CMHC)

CKD & Diabetes Management: The Role of GLP-1 RAs in Kidney Protection

FEATURING Katherine R. Tuttle

1,247 views
January 15, 2021
7

Cardiometabolic Health Congress (CMHC)

60 y/o Woman With a 10-Year History of T2DM, HTN, and Hyperlipidemia: What Medication Would You Choose for Glycemic Control?

FEATURING Neil Skolnik, Robert Eckel, Darren K. Mcguire, Katherine R. Tuttle

57 views
January 15, 2021

Cardiometabolic Health Congress (CMHC)

63 y/o Male With T2DM, HTN, Hyperlipidemia, HrEF (EF-35%): Which Additional Medications Are Needed, and Why?

FEATURING Neil Skolnik, Robert Eckel, Darren K. Mcguire, Katherine R. Tuttle

36 views
January 15, 2021

Cardiometabolic Health Congress (CMHC)

57 y/o Male With T2DM, HTN, Hyperlipidemia, PE-BP 138/86, and 18 % ACC ASCVD 10-Year Risk: What Are the Treatment Strategies?

FEATURING Neil Skolnik, Robert Eckel, Darren K. Mcguire, Katherine R. Tuttle

20 views
January 15, 2021

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Medicine: What Are the Trends in Mortality, Risk & Blood Pressure Control?

FEATURING Keith Ferdinand

348 views
January 15, 2021

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Medicine: Does SGLT2i Improve HFrEF Symptoms, QOL, Reduce the Risk of Hospitalization and CV Mortality? Why Cardiologist Must Intervene in T2D?

FEATURING Keith Ferdinand

103 views
January 15, 2021
1